EXCERPT:
BLACKSTOCK: "Thank you so much Reverend Al for having me. Actually, the rebound is more common than the clinical studies had initially shown. Initially we thought it was single digit percentages, about 2 to 3 percent of patients that take Paxlovid would have the rebound, but now in the real world situation, we see that number is much higher, about 20 to 30 percent. What is important to note is that this is not a reinfection. This is not mean that people with the virus are resistant to Paxlovid. It requires, we need more data and study on Paxlovid to determine whether or not that five-day course is an adequate duration of treatment.”